Furthermore, we knocked down E2F1 in PTTG3P-overexpressing NSCLC cells, and the results showed that E2F1 knockdown could significantly inhibit the PTTG3P overexpression-induced NSCLC cell growth acceleration and migration increase. The gene discussed is PTTG3P; the disease is non-small cell lung carcinoma.